Stabilization of the human cytomegalovirus UL136p33 reactivation determinant overcomes the requirement for UL135 for replication in hematopoietic cells.

Animals Humans Mice Antigens, CD34 / genetics Cytomegalovirus / physiology Latent Infection Mice, Inbred NOD Viral Proteins / genetics Virus Latency Virus Replication
UL135 UL136 cytomegalovirus herpesvirus latency reactivation

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
31 08 2023
Historique:
medline: 1 9 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Human cytomegalovirus (HCMV) is a beta herpesvirus that persists indefinitely in the human host through a latent infection. The polycistronic

Identifiants

DOI: 10.1128/jvi.00148-23 PMID: 37565749 PMC: PMC10506481
pubmed: 37565749
doi: 10.1128/jvi.00148-23
pmc: PMC10506481
doi:

Substances chimiques

Antigens, CD34 0
UL136 protein, human herpesvirus 5 0
Viral Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0014823

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI127335
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023074
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI079059
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI079059
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Virol. 2014 Jun;88(11):6047-60
pubmed: 24623439
Front Immunol. 2018 Jan 10;8:1953
pubmed: 29367854
J Perinatol. 2021 Feb;41(2):315-323
pubmed: 32884104
J Immunol. 2014 Mar 1;192(5):2143-55
pubmed: 24501199
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18764-18770
pubmed: 32694203
J Virol. 2013 Apr;87(8):4665-71
pubmed: 23408605
J Virol. 1996 Jan;70(1):78-83
pubmed: 8523595
J Clin Invest. 2011 May;121(5):1673-80
pubmed: 21659716
mBio. 2022 Aug 30;13(4):e0104222
pubmed: 35946797
Biochim Biophys Acta. 2014 Jan;1843(1):216-21
pubmed: 23684952
Blood. 2003 Jan 15;101(2):407-14
pubmed: 12393659
Adv Virus Res. 2022;112:31-85
pubmed: 35840181
Cell Host Microbe. 2014 Aug 13;16(2):201-214
pubmed: 25121749
mBio. 2018 Apr 24;9(2):
pubmed: 29691342
J Virol. 1997 Feb;71(2):981-7
pubmed: 8995616
JCI Insight. 2022 Jan 11;7(1):
pubmed: 35014624
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
J Virol. 2018 Sep 26;92(20):
pubmed: 30089695
J Virol. 2008 Feb;82(4):1638-46
pubmed: 18057245
Virology. 2007 Oct 25;367(2):334-8
pubmed: 17590404
mSphere. 2021 Jan 6;6(1):
pubmed: 33408225
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13585-90
pubmed: 14593199
Curr Top Microbiol Immunol. 2008;325:1-19
pubmed: 18637497
Viruses. 2020 Jul 01;12(7):
pubmed: 32630219
J Virol. 2016 Dec 16;91(1):
pubmed: 27795414
Curr Top Microbiol Immunol. 2008;325:417-70
pubmed: 18637519
PLoS One. 2015 Mar 23;10(3):e0120946
pubmed: 25799165
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3263-8
pubmed: 12626766
J Gen Virol. 2004 May;85(Pt 5):1301-1312
pubmed: 15105547
Oncogene. 2007 Jun 14;26(28):4059-70
pubmed: 17224909
J Virol. 2009 Jun;83(11):5615-29
pubmed: 19297488
J Virol. 2015 Jul;89(13):6536-50
pubmed: 25878111
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20860-20867
pubmed: 32788362
J Gen Virol. 2008 Feb;89(Pt 2):359-368
pubmed: 18198366
PLoS Pathog. 2019 Nov 14;15(11):e1008037
pubmed: 31725811
Hematology Am Soc Hematol Educ Program. 2011;2011:305-9
pubmed: 22160050
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5978-83
pubmed: 10811905
J Virol. 2006 Jun;80(11):5611-26
pubmed: 16699042
Viruses. 2018 Aug 03;10(8):
pubmed: 30081449
J Clin Virol. 2009 Dec;46 Suppl 4:S6-10
pubmed: 19800841
Annu Rev Biophys Biomol Struct. 1998;27:199-224
pubmed: 9646867
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
Methods Mol Biol. 2021;2244:83-101
pubmed: 33555583
J Virol. 2004 May;78(9):4599-608
pubmed: 15078942
J Immunol. 2013 Jun 1;190(11):5363-72
pubmed: 23636061
Acta Virol. 2020;64(2):117-130
pubmed: 32551781
PLoS Pathog. 2011 Dec;7(12):e1002444
pubmed: 22241980
J Virol. 2014 Dec;88(24):14412-25
pubmed: 25297993
Virol J. 2021 Oct 18;18(1):207
pubmed: 34663377
J Virol. 2014 Jun;88(11):5987-6002
pubmed: 24623432
J Virol. 2005 Feb;79(4):2115-23
pubmed: 15681414
Viruses. 2021 Jun 04;13(6):
pubmed: 34200083
Nat Methods. 2014 May;11(5):508-20
pubmed: 24781324
Rev Med Virol. 2019 May;29(3):e2034
pubmed: 30706584
mBio. 2016 Mar 01;7(2):e01986
pubmed: 26933055
J Virol. 1996 Sep;70(9):6340-6
pubmed: 8709262
Nucleic Acids Res. 2005 Feb 24;33(4):e36
pubmed: 15731329
Front Cell Infect Microbiol. 2020 Jul 31;10:368
pubmed: 32850474
Rev Med Virol. 2011 Jul;21(4):240-55
pubmed: 21674676
J Virol. 2011 Jan;85(2):663-74
pubmed: 21047969
J Virol. 2023 Jul 27;97(7):e0075823
pubmed: 37338407
J Infect Dis. 2020 Mar 5;221(Suppl 1):S1-S8
pubmed: 32134479
Science. 2012 Nov 23;338(6110):1088-93
pubmed: 23180859
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14976-81
pubmed: 14657367
PLoS Pathog. 2016 May 24;12(5):e1005655
pubmed: 27218650
J Virol. 2017 Aug 10;91(17):
pubmed: 28637762
Trends Biochem Sci. 2014 Dec;39(12):612-8
pubmed: 25456048
J Virol. 2010 Sep;84(18):9472-86
pubmed: 20592073
Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17492-17497
pubmed: 31409717
Cell Host Microbe. 2010 Sep 16;8(3):284-91
pubmed: 20833379
J Virol. 2013 Jun;87(11):6359-76
pubmed: 23536674
J Clin Virol. 2015 Feb;63:53-8
pubmed: 25600606
J Gen Virol. 2003 Sep;84(Pt 9):2511-2516
pubmed: 12917473

Auteurs

Melissa A Moy (MA)

Cancer Biology Graduate Interdisciplinary Program, University of Arizona , Tucson, Arizona, USA.
Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.
BIO5 Institute, University of Arizona , Tucson, Arizona, USA.

Donna Collins-McMillen (D)

Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.
BIO5 Institute, University of Arizona , Tucson, Arizona, USA.

Lindsey Crawford (L)

Vaccine and Gene Therapy Institute, Oregon Health and Science University , Beaverton, Oregon, USA.

Christopher Parkins (C)

Vaccine and Gene Therapy Institute, Oregon Health and Science University , Beaverton, Oregon, USA.

Sebastian Zeltzer (S)

Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.
BIO5 Institute, University of Arizona , Tucson, Arizona, USA.

Katie Caviness (K)

Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.
BIO5 Institute, University of Arizona , Tucson, Arizona, USA.
Graduate Interdisciplinary Program in Genetics, University of Arizona , Tucson, Arizona, USA.

Syed Shujaat Ali Zaidi (SSA)

Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.

Patrizia Caposio (P)

Vaccine and Gene Therapy Institute, Oregon Health and Science University , Beaverton, Oregon, USA.
ORCID: 0000-0001-7579-849X

Felicia Goodrum (F)

Cancer Biology Graduate Interdisciplinary Program, University of Arizona , Tucson, Arizona, USA.
Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.
BIO5 Institute, University of Arizona , Tucson, Arizona, USA.
Graduate Interdisciplinary Program in Genetics, University of Arizona , Tucson, Arizona, USA.
ORCID: 0000-0002-6646-7290

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes CD › Antigènes CD34 › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Virus › Virus à ADN › Herpesviridae › Betaherpesvirinae › Cytomegalovirus › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Infection › Infection latente › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée NOD › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Latence virale › Stabilization of the human cytomegalovirus...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Réplication virale › Stabilization of the human cytomegalovirus...